New York, United States, March 11th, 2025, FinanceWire
Junction, a healthcare infrastructure company, has announced an $18 million Series A funding round led by Creandum, with participation from Y Combinator, Point Nine, Amino Collective, and Inflect Health. The investment will support Junction’s efforts to enhance healthcare infrastructure, facilitating seamless data integration and improving patient-centered care. The funding announcement coincides with the company’s rebrand from Vital to Junction, alongside the launch of a new brand identity and website.
Addressing Gaps in Healthcare Infrastructure
The shift toward decentralized healthcare has created a growing need for accessible, high-quality physiological data beyond hospital settings. However, existing healthcare infrastructure remains reliant on legacy lab vendors and medical devices, presenting challenges in data accessibility, workflow efficiency, and care delivery.
Currently, 60% of U.S. adults have a chronic disease, yet nearly 20% of lab tests go incomplete, often due to inefficient processes and fragmented systems. Care teams spend significant time managing manual workflows, which can lead to delayed diagnoses and increased costs. Moreover, negative Net Promoter Scores (NPS) from companies relying on traditional infrastructure highlight the need for more effective solutions (e.g., Health Gorilla: -20, Change Healthcare: -51).
Junction’s Solution
Junction aims to modernize healthcare infrastructure by enabling organizations to streamline data collection, automate workflows, and enhance patient engagement. Its platform offers:
- Nationwide lab test ordering across all 50 states, integrating with more than 10 lab networks, including Labcorp and Quest, for both in-person and at-home testing.
- Automated clinical workflows that minimize manual tasks for healthcare providers, improving efficiency and reducing operational costs.
- Real-time lab status updates and patient communication tools to reduce uncertainty and improve engagement.
- Connectivity with over 500 wearable and medical devices, allowing for a more comprehensive view of patient health.
Industry Perspective
“Data remains a key constraint in unlocking the potential of AI and other technologies in healthcare,” said Sabina Wizander, Partner at Creandum. “Many healthcare systems still rely on outdated infrastructure, making it difficult to optimize care delivery. Junction addresses this challenge by providing a modernized platform for lab testing and device data integration, improving both patient experiences and preventative care outcomes.”
Market Adoption and Growth
Junction currently supports over 140 healthcare organizations, including digital health companies such as Found, Parsley Health, and Evidation. The platform processes more than 500,000 tests annually and integrates with over 2 million connected devices.
A 2020 McKinsey report estimates that up to $250 billion of U.S. healthcare spending could shift to virtual care delivery, underscoring the demand for scalable infrastructure solutions. Junction is positioned to facilitate this transition by bridging the gaps in data collection, automation, and preventative care.
Rebrand to Junction
“The rebrand from Vital to Junction reflects our commitment to serving as the connection point for healthcare systems, data, and patient care,” said Maitham Dib, Founder and CEO of Junction. “Our goal remains the same: to provide the infrastructure that supports the next generation of healthcare innovation.”
About Junction
Junction provides healthcare organizations with infrastructure solutions for lab testing, device data integration, and automated clinical workflows. By enabling seamless data exchange and operational efficiency, Junction helps organizations improve patient outcomes while reducing costs. Founded by former Babylon Health engineer Maitham Dib, Junction is backed by Creandum, Y Combinator, and other leading investors.
More information can be found here: junction.com